AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy (Q38558611)
Jump to navigation
Jump to search
scientific article published on August 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy |
scientific article published on August 2015 |
Statements
1 reference
AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy (English)
1 reference
Jingjing Wu
1 reference
Jiaping Fu
1 reference
Mingzhi Zhang
1 reference
Delong Liu
1 reference
1 August 2015
5 references
3 April 2019
27 September 2019
27 November 2019
13 December 2019
5 references
3 April 2019
27 September 2019
27 November 2019
13 December 2019
96
1 reference
4 references
3 April 2019
27 September 2019
27 November 2019
13 December 2019
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference